Re: Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer

Re: Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer

Bibliographic Details
Main Author:	Özgür Yaycıoğlu
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2018-06-01
Series:	Journal of Urological Surgery
Online Access:	http://jurolsurgery.org/archives/archive-detail/article-preview/re-clinical-and-genomic-characterization-of-low-pr/18505

Similar Items

Re: Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Arm
by: Özgür Yaycıoğlu
Published: (2017-03-01)

Re: Metastatic Prostate Cancer in Men Initially Treated with Active Surveillance
by: Özgür Yaycıoğlu
Published: (2016-09-01)

Re: Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis
by: Özgür Yaycıoğlu
Published: (2016-12-01)

Re: Prognosis of prostate cancer and prostate - specific antigen levels
by: Beuy Joob, et al.

Re: Transurethral Resection of the Prostate Biopsy of Suspected Anterior Prostate Cancers Identified by Multiparametric Magnetic Resonance Imaging: A Pilot Study of a Novel Technique
by: Özgür Yaycıoğlu
Published: (2016-06-01)

Re: More Extensive Lymph Node Dissection at Radical Prostatectomy is Associated with Improved Outcomes with Salvage Radiotherapy for Rising Prostate-specific Antigen After Surgery: A Long-term, Multi-institutional Analysis
by: Özgür Yaycıoğlu
Published: (2018-09-01)

Re: A Prospective Study of Health-Related Quality-of-Life Outcomes for Patients with Low-Risk Prostate Cancer Managed by Active Surveillance or Radiation Therapy
by: Özgür Yaycıoğlu
Published: (2017-09-01)

Prostate-specific antigen and free prostate-specific antigen/prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer
by: Amal A. Hussein, et al.
Published: (2020-12-01)

Association between low prostate-specific antigen levels and greater disease progression in high-grade locally-advanced prostate cancer
by: Yu-Cheng Lu, et al.
Published: (2021-01-01)

The Role of Radical Prostatectomy in the Treatment of Patients with High-Risk Prostate Cancer
by: Barış Kuzgunbay, et al.
Published: (2015-09-01)

Prostatic specific antigen for prostate cancer detection
by: Lucas Nogueira, et al.
Published: (2009-10-01)

Prostate specific antigen negative prostate cancer
by: Birtle, A. J.
Published: (2005)

Prostate-Specific Antigen Doubling Time as a Predictor of Gleason Grade in Prostate Cancer
by: Mohammad Reza Nowroozi, et al.
Published: (2009-02-01)

Quality control and GMP synthesis of68Ga-prostate-specific membrane antigen-11 for detection of low- and high-grade prostate cancer
by: Majid Assadi, et al.
Published: (2020-01-01)

Hepsin immunohistochemical expression in prostate cancer in relation to Gleason′s grade and serum prostate specific antigen
by: Madhu Mati Goel, et al.
Published: (2011-01-01)

The Role of Prostate-Specific Antigen in Prostate Cancer Screening
by: Constantin Traian Vasile, et al.
Published: (2014-06-01)

Value of Prostate-Specific Antigen and Prostate-Specific Antigen Density in Detection of Prostate Cancer in an Iranian Population of Men
by: Mahyar Ghafoori, et al.
Published: (2009-08-01)

Re: The influence of statins on prostate-specific antigen levels
by: Konstantinos N. Stamatiou
Published: (2009-02-01)

High grade intraepithelial neoplasia of prostate is associated with values of prostate specific antigen related parameters intermediate between prostate cancer and normal levels
by: Nermina Obralic, et al.
Published: (2011-11-01)

Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer
by: Sinan Avci, et al.
Published: (2020-04-01)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
by: Ahmad Anies Shahab, et al.
Published: (2013-03-01)

TERTIARY GLEASON GRADE ANDULTRASENSITIVE PROSTATE-SPECIFIC ANTIGEN LEVELS AS PROGNOSTIC FACTOR OF PROSTATE CANCER RECURRENCE
by: I. N. Ognerubova
Published: (2014-07-01)

TERTIARY GLEASON GRADE ANDULTRASENSITIVE PROSTATE-SPECIFIC ANTIGEN LEVELS AS PROGNOSTIC FACTOR OF PROSTATE CANCER RECURRENCE
by: I. N. Ognerubova
Published: (2014-07-01)

Controversies in Prostate Cancer Screening: is the Prostate Specific Antigen useful?
by: Pablo Yago Giménez, et al.
Published: (2019-12-01)

Updates of prostate cancer staging: Prostate-specific membrane antigen
by: Niranjan J Sathianathen, et al.
Published: (2016-12-01)

Optimal use of prostate specific antigen for prostate cancer screening
by: Miočinović Ranko, et al.
Published: (2013-01-01)

Prostate-specific membrane antigen-mediated theragnostics in prostate cancer
by: Seung-hwan Jeong, et al.
Published: (2021-09-01)

Advanced prostatic carcinomas with low serum levels of prostate-specific antigen
by: Cerović Snežana J., et al.
Published: (2002-01-01)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
by: Nouira Yassin, et al.
Published: (2010-12-01)

Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan
by: Yasuhide Kitagawa, et al.
Published: (2014-12-01)

Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen?
by: Pinuccia Faviana, et al.
Published: (2021-03-01)

Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels
by: Andreas Bohle
Published: (2009-10-01)

CLINICAL SIGNIFICANSE OF PROSTATE-SPECIFIC ANTIGEN IN BREAST CANCER PATIENTS
by: N. S. Sergeeva, et al.
Published: (2020-12-01)

THE PRETREATMENT PROSTATE-SPECIFIC ANTIGEN DOUBLING TIME: CLINICAL AND PROGNOSTIC VALUES IN PATIENTS WITH PROSTATE CANCER
by: G. M. Zharinov, et al.
Published: (2014-07-01)

Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection
by: T. Yoneyama, et al.
Published: (2020-07-01)

THE PRETREATMENT PROSTATE-SPECIFIC ANTIGEN DOUBLING TIME: CLINICAL AND PROGNOSTIC VALUES IN PATIENTS WITH PROSTATE CANCER
by: G. M. Zharinov, et al.
Published: (2014-07-01)

Benign prostatic hyperplasia and prostate-specific antigen
by: Pejčić Tomislav, et al.
Published: (2015-01-01)

Clinical utility of prostate-specific antigen mass ratio for prediction of prostate cancer detection on a repeated prostate biopsy
by: Won Ki Lee, et al.
Published: (2014-08-01)

The role of prostate-specific antigen in the prediction of hormone-sensitive prostate cancer
by: A. A. Gritskevich, et al.
Published: (2015-12-01)

Prostate specific antigen change after administration of nimotuzumab in prostate cancer
by: Kamon Chaiyasit, et al.
Published: (2013-01-01)